Comparison of micellar and reversed-phase liquid chromatography for determination of sulfamethoxazole and trimethoprim

Chromatographia

Volumn 61, Issue 9-10, 2005, Pages 455-463

  Kulikov, A U ^a   Verushkin, A G ^a   Loginova, L P ^b  

^a Scientific and Expert Pharmacopoeial Centre   (Ukraine)

^b V N KARAZIN KHARKIV NATIONAL UNIVERSITY   (Ukraine)

Author keywords

Column liquid chromatography; Micellar liquid chromatography; Pharmaceutical products; Sodium dodecyl sulfate; Sulfamethoxazole and trimethoprim

Indexed keywords

BUFFER; BUTANOL; DODECYL SULFATE SODIUM; PHOSPHATE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ARTICLE; DRUG DETERMINATION; INTERMETHOD COMPARISON; MICELLAR LIQUID CHROMATOGRAPHY; PH MEASUREMENT; PHASE SEPARATION; PRIORITY JOURNAL; REVERSED PHASE LIQUID CHROMATOGRAPHY; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; ULTRAVIOLET SPECTROSCOPY; VALIDATION PROCESS;

EID: 20044384562     PISSN: 00095893     EISSN: None     Source Type: Journal    
DOI: 10.1365/s10337-005-0536-5     Document Type: Article

References (35)

1. Berthod A, Garcia-Alvarez-Coque MC (2000) Micellar liquid chromatography. Marcel Dekker, New York
2. Weinberger R, Yarmchuk P, Clin-Love LJ (1993) Anal Chem 65:2346-2352
3. Ruiz-Angel MJ, Carda-Broch S, Simo-Alfonso EF, Garcia-Alvarez-Coque MC (2003) J Pharm Biomed Anal 32:71-84
4. Monferrer-Pons L, Capella-Peiro ME, Gil-Agusti M, Esteve-Romero J (2003) J Chromatogr A 984:223-231
5. Ruiz-Angel MJ, Carda-Broch S, Torres-Lapasio JR, Simo-Alfonso EF, Garcia-Alvarez-Coque MC (2002) Anal Chim Acta 454:109-123
6. Ruiz-Angel MJ, Carda-Broch S, Garcia-Alvarez-Coque MC, Berthod A (2004) J Chromatogr A 1030:279-288
7. Gonzalo-Lumbreras R, Izquierdo-Hornillos R (2003) J Pharm Biomed Anal 32:433-439
8. Mutscheler E, Derendorf H (1995) Drug action. Basic principles and therapeutic aspects. Medpharm Scientific, Stuttgart
9. Hassouna MEM (1997) Anal Lett 30:2341-2346
10. Abdul Kamal Nazer M, Shaber TK, Riyazuddin P (2001) Chem Pharm Bull 49:278-284
11. Hung CT, Perrier DG (1985) J Liq Chromatogr 8:521-526
12. Akay C, Ozkan SA (2002) J Pharm Biomed Anal 30:1207-1213
13. Hess S, Akermann M, Ropte D, Eger K (2001) J Pharm Biomed Anal 25:531-538
14. Barbarin N, Henion JD, Wu Y (2002) J Chromatogr A 970:141-154
15. British Pharmacopoeia (2001) Version 2.0 [CD-ROM] The Stationary Office Ltd
16. United States Pharmacopoeia/National Formulary, 24th edn (2000) United States Pharmacopoeial Convention, Rockville, MD
17. Ronn AM, Mutabingwa TK, Angelo HR, Fuursted K, Bygbjerg IC (1999) Ther Drug Monit 21:609-614
18. Pfeifer T, Tuerk J, Bester K, Spiteller M (2002) Rapid Commun Mass Spectrom 16:663-669
19. Teshima D, Otsubo K, Makino K, Oishi R (2004) Biomed Chromatogr 18:51-54
20. Kulikov AU, Verushkin AG (2004) Chromatographia 60:33-38
21. Gonzalo-Lumbreras R, Izquierdo-Hornillos R (2003) J Pharm Biomed Anal 32:433-439
22. Ghorbani AR, Momenbeik F, Fhorasani JH, Amini MK (2004) Anal Bioanal Chem 379:439-444
23. Yang S, Khaledi AG (1995) J Chromatogr A 692:311-318
24. Simo Alfonso EF, Ramis Ramos G, Garcia Alvarez-Coque MC, Esteve Romero JS (1995) J Chromatogr B 670:183-187
25. Garcia Alvarez-Coque MC, Simo Alfonso EF, Ramis Ramos G, Esteve Romero JS (1995) J Pharm Biomed Anal 13:237-345
26. Vander Heyden Y, Jimidar M, Hund E, Niemeijer N, Peeters R, Smeyers-Verbeke J, Massart LD, Hoogmartens J (1999) J Chromatogr A 845:145-154
27. Shabir GA (2003) J Chromatogr A 987:57-66
28. Kulikov AU, Verushkin AG (2002) Kharkov University Bulletin, No. 549, Chemical Series (Russian) 8(31):57-65
29. Dolan JW (2004) LC-GC 27:432-435
30. Kulikov AU, Loginova LP, Samokhina LV (2004) Pharmacom (Russian) 1:22-53
31. Ruiz-Angel MJ, Torres-Lapasio JR, Garcia-Alvarez-Coque MC (2004) J Chromatogr A 1022:51-65
32. Strasters JK, Breyer ED, Rodgers AH, Khaledi MG (1990) J Chromatogr 511:17-25
33. Kulikov AU, Loginova LP, Samokhina LV (2003) Chromatographia 57:463-469
34. International Conference of Harmonization (1995) Q2A: Text on validation of analytical procedures. US FDA Federal Register, vol 60, March 1995, p 11260
35. International Conference of Harmonization (1997) Q2B: Validation of analytical procedures: methodology. US FDA Federal Register, vol 62, May 1997, p 27463